Sensorion Presents Gene Therapy Research at ESGCT Annual Congress
Sensorion will present gene therapy research at the ESGCT annual congress, according to the headline.
Related stories
SPIMACO Reports Q3 Net Loss of SAR 33.3 Million
M impact | EQUITY | Oct 29, 2026, 03:04 PM UTC
Lowe's Companies Shares Hit 7-week High
Lowe's Companies shares increased to 204.54 USD, the highest since September 2026. Over the past 4 weeks, Lowe's Companies gained 10.84%, and in the last 12 months, it decreased 14
L impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Fortrea Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Analysts Update Linde Price Targets After Q3 Results
Bernstein maintained an Outperform rating and a $562 price target; Mizuho raised its target to $583.
M impact | EQUITY | Oct 29, 2026, 03:03 PM UTC
Al Baha Reports Q3 Net Profit of SAR 2.7 Million
M impact | EQUITY | Oct 29, 2026, 03:02 PM UTC
Shell Posts Highest Quarterly Profit Since 2022, Raises Buyback
Shell reported third-quarter net profit of $10.81 billion, above analysts’ average estimate of $10.33 billion. Record refining margins and stronger LNG performance helped the resul
M impact | EQUITY | Oct 29, 2026, 03:01 PM UTC